McDonald's 2025 Financial Report: Performance Exceeds Expectations, Strong Global Same-Store Sales Growth

robot
Abstract generation in progress

Economy Observation Network reports that McDonald’s announced its Q4 and full-year 2025 financial results on February 11, 2026, exceeding market expectations.

Performance Overview

Q4 Key Financial Metrics Surpass Expectations

Revenue: $7.009 billion, up 6% year-over-year (fixed exchange rates), beating market forecasts.

Net profit: $2.164 billion, up 4% year-over-year.

Adjusted EPS: $3.12, higher than analyst expectations of $3.04.

Global same-store sales: increased by 5.7%, significantly above the market expectation of 3.7%.

Strong Regional Performance

U.S. Market: Same-store sales grew by 6.8%, marking the third consecutive quarter of growth, mainly driven by value meal strategies (such as $5 combos) attracting price-sensitive consumers and increasing foot traffic.

International Markets (e.g., UK, Germany, Australia): Same-store sales increased by 5.2%, with nearly all markets showing growth.

International Licensing Markets (e.g., Japan, China): Same-store sales rose by 4.5%. Despite macroeconomic pressures, China maintained stable market share, adding over 1,000 new restaurants in 2025.

Full-Year Steady Growth

Full-year revenue: $26.885 billion, up 2%.

Full-year net profit: $8.563 billion, up 3%.

Cash flow: Operating cash flow reached $10.55 billion, demonstrating financial resilience.

Strategic Initiatives

Store Expansion: In 2025, opened 2,275 new restaurants globally; plans to add approximately 2,600 in 2026 (net increase of 2,100), including about 1,000 in China, aiming for 50,000 stores worldwide by 2027.

Product Innovation: Launching energy drinks, specialty iced coffees, and strengthening high-protein product promotion to address health trends in 2026.

Capital Expenditure: Expected investment of $3.7 to $3.9 billion in 2026, mainly for new store openings.

Company Status

CEO Chris Kempsinski stated that the value-for-money strategy effectively increased foot traffic, and no substantial impact from GLP-1 weight-loss drugs has been observed on the business.

The company expects operating profit margins to remain in the mid-to-high 40% range in 2026.

The above information is compiled from public sources and does not constitute investment advice.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin